rifampicin
| Uses: | MRCEM pathology/Microbiology/Tuberculosis, Infective endocarditis, leprosy, prophylaxis for meningococcal meningitis |
|---|---|
| Mechanism of action | Inhibits bacterial RNA polymerase |
| Dose | 600mg OD |
| Pharmacokinetics | Absorption PO Distribution Metabolism Elimination bile - deacetylation during enterohepatic circulation. Active metabolite. |
| Time course of action | |
| Adverse effects | Orange tint to bodily secretions (sweat, tears) GI upset P450 inducer = ↓ action of warfarin, etc. |